Serum Endocan Level and the Severity of Coronary Artery Disease

Angiology

Volumn 66, Issue 8, 2015, Pages 727-731

  Kose, Murat ^a   Emet, Samim ^a   Akpinar, Timur Selcuk ^a   Kocaaga, Mehmet ^a   Cakmak, Ramazan ^a   Akarsu, Murat ^b   Yuruyen, Gulden ^b   Arman, Yucel ^b   Tukek, Tufan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b OKMEYDANI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

acute coronary syndrome; coronary artery disease; endocan; endothelial specific molecule 1; Gensini score; SYNTAX score

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOCAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; PROTEOGLYCAN; UNCLASSIFIED DRUG; ESM1 PROTEIN, HUMAN; TUMOR PROTEIN;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE SEVERITY; FEMALE; GENSINI SCORE; HUMAN; INVESTIGATIVE PROCEDURES; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MIDDLE AGED; PILOT STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RIGHT CORONARY ARTERY; SYNTAX SCORE; AGED; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; PREDICTIVE VALUE; SEVERITY OF ILLNESS INDEX; UPREGULATION;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROTEOGLYCANS; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 84939521348     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319714548870     Document Type: Article

References (17)

1. WHO Fact sheet N8310. Updated May 2014. http://www.who.int/mediacentre/factsheets/fs310/en/index.html. Accessed July 2014.
2. Widimsky P, Wijns W, Fajadet J,. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J. 2010; 31 (8): 943-957.
3. Menon P, Kocher ON, Aird WC,. Endothelial cell specific molecule-1 (ESM-1), a novel secreted proteoglycan stimulates vascular smooth muscle cell proliferation and migration. Circulation. 2011; 124 (21): A15455.
4. Bechard D, Scherpereel A, Hammad H,. Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1. J Immunol. 2001; 167 (6): 3099-3106.
5. Balta I, Balta S, Demirkol S,. Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease. Br J Dermatol. 2013; 169 (5): 1066-1070.
6. Balta I, Balta S, Koryurek OM,. Serum endocan levels as a marker of disease activity in patients with Behcet disease. J Am Acad Dermatol. 2014; 70 (2): 291-296.
7. Balta S, Mikhailidis DP, Demirkol S,. Endocan-a novel inflammatory indicator in newly diagnosed patients with hypertension: a pilot study. Angiology. 2014; 65 (9): 773-777.
8. Balta S, Demirkol S, Celik T,. Association between coronary artery ectasia and neutrophil-lymphocyte ratio. Angiology. 2013; 64 (8): 627-632.
9. Scherpereel A, Depontieu F, Grigoriu B,. Endocan, a new endothelial marker in human sepsis. Crit Care Med. 2006; 34 (2): 532-537.
10. Gensini GG,. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983; 51 (3): 606.
11. Zakynthinos E, Pappa N,. Inflammatory biomarkers in coronary artery disease. J Cardiol. 2009; 53 (3): 317-333.
12. Ley K, Laudanna C, Cybulsky MI, Nourshargh S,. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007; 7 (9): 678-689.
13. Roudnicky F, Poyet C, Wild P,. Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis. Cancer Res. 2013; 73 (3): 1097-1106.
14. Chen LY, Liu X, Wang SL, Qin CY,. Over-expression of the endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion. J Int Med Res. 2010; 38 (2): 498-510.
15. Liu N, Zhang LH, Du H,. Overexpression of endothelial cell specific molecule-1 (ESM-1) in gastric cancer. Ann Surg Oncol. 2010; 17 (10): 2628-2639.
16. Yilmaz MI, Siriopol D, Saglam M,. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease [published online July 2, 2014]. Kidney Int. 2014. doi:10.1038/ki.2014.227.
17. Rennel E, Mellberg S, Dimberg A,. Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer. Exp Cell Res. 2007; 313 (7): 1285-1294.